Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
Conditions
- NSCLC
- EGFR Activating Mutation
- EGFR-TKI-resistant Non-Small Cell Lung Cancer
- Trop2
- PET/CT Imaging
Interventions
- DIAGNOSTIC_TEST: receive treatment with TROP2-targeted ADC and targeted molecular PET/CT imaging using ⁶⁸Ga-MY6349 injection
Sponsor
Zhou Chengzhi
Collaborators